Lam Research Nearly Triples in a Year: Is the Stock Still Worth Buying?

Lam Research reported fiscal Q4 2026 revenue of a record $6.72 billion, up 30% year over year and 0.7% above consensus, while non-GAAP EPS rose 37% to $1.82, beating estimates by 7.7%. Gross margin expanded 170bps to 35.0% and operating margin increased 400bps to 38.4%, supported by pricing, scale and product mix. Consensus forecasts revenue growth of 48.4% and EPS growth of 60.6% in fiscal 2027, underpinned by AI-chip, HBM and advanced-packaging equipment demand, though the stock trades at a premium 31.72x forward P/E versus 13.64x for the industry.

Analysis

The key underwriting question is no longer whether AI wafer-fab-equipment demand is real, but whether Lam can sustain incremental margins as customers shift from leading-edge logic into HBM, DRAM and advanced-packaging capacity. Lam's etch intensity is especially leveraged to 3D memory layer counts and backside-power adoption, but these are lumpy, node-transition-driven spends; a delay at TSM or Samsung can produce a sharper order deceleration than revenue history implies. The equity therefore has greater sensitivity to forward WFE bookings and customer concentration commentary than to another modest quarterly revenue beat.

At a material premium to AMAT, LRCX needs both estimate delivery and further confidence that margin gains are structural rather than favorable mix. The near-term risk is a classic semicap de-rating: even if earnings rise, a 4-6x forward-P/E compression would offset much of a single year of estimate growth if memory capex or China demand rolls over. Over the next 1-3 months, watch management commentary on 2027 WFE, China mix, HBM-related shipments and deferred revenue; over 6-18 months, the upside case requires advanced packaging and backside-power to become a durable equipment-intensity cycle rather than a one-time qualification wave.

Consensus appears to treat all AI-linked equipment exposure as interchangeable. AMAT may offer the cleaner risk-adjusted expression if advanced packaging broadens beyond a small set of memory and foundry customers, while AMKR is a higher-beta downstream confirmation vehicle but carries lower technological moat and greater utilization risk. A negative signal would be AI compute demand remaining strong while foundry/memory equipment orders soften—evidence that customers are digesting installed capacity rather than expanding it.

Key Decisions for Investors

• Do not chase LRCX into strength; initiate only on a post-earnings pullback or after confirmation that forward WFE guidance and HBM/advanced-packaging orders are accelerating. Size as a 3-6 month tactical long, with thesis invalidated by a material cut to fiscal-year revenue guidance or sequential gross-margin compression.
• Prefer a 6-12 month relative-value pair: long AMAT / short LRCX in equal beta-adjusted dollars. This expresses the risk that Lam's valuation premium has discounted more of the AI equipment cycle, while AMAT retains broad exposure to deposition, packaging and foundry spending. Exit if Lam demonstrates sustained order growth and margin expansion materially above AMAT for two reporting periods.
• For existing LRCX longs, reduce exposure ahead of the next earnings print unless implied volatility is below realized volatility; retain a core position only with a defined hedge through SOXX puts or a short SOXX overlay. The primary tail risk is sector-wide multiple compression from a memory-capex pause, which diversification across equipment names will not fully offset.
• Set an event-driven alert around TSM, Samsung and major memory-producer capex commentary. Upward revisions to 2027 capex would support adding LRCX and AMAT; evidence of HBM capacity digestion or reduced China demand should shift exposure toward the AMAT/LRCX relative-value trade rather than outright semicap longs.